Cover Image for AI, Drug Discovery🧬, Precision Med 💊 , French 🥐 Breakfast Startup Pitch Session 🎤
Cover Image for AI, Drug Discovery🧬, Precision Med 💊 , French 🥐 Breakfast Startup Pitch Session 🎤
75 Went

AI, Drug Discovery🧬, Precision Med 💊 , French 🥐 Breakfast Startup Pitch Session 🎤

Hosted by Arnaud AUGER & Silvia Pascual
Registration
Past Event
Please click on the button below to join the waitlist. You will be notified if additional spots become available.
About Event

Come meet the best AI startups in Drug Discovery and Precision Medicine coming from France to build the future of health with you in San Francisco during JPMHC—a breakfast you won’t want to miss.

Enjoy fresh coffee ☕️, French croissants 🥐, and a spectacular sunrise view 🌅 over the Bay Bridge 🌉 while connecting with a curated group of pharma and TechBio innovation leaders, clinical decision-makers, and top US investors in an intimate, high-signal setting.

⭐️ First, Owkin—France’s leading AI TechBio, a unicorn, and a trusted partner to major pharmaceutical companies including Sanofi, Bristol Myers Squibb, and AstraZeneca—will share an exclusive update. This is a rare opportunity to hear directly from one of Europe’s most advanced AI-driven biotech platforms on how AI is delivering real impact at scale across clinical development and R&D decision-making.

🎤 Then, we will move into a fast-paced startup pitch session: a carefully selected lineup of French AI companies, each allocated up to 10 minutes of total speaking time, which they may split freely between pitch and Q&A (e.g. 5 minutes pitch + 5 minutes Q&A, or 7 minutes pitch + 3 minutes Q&A). The session offers an executive-level view of their technology, validation, and concrete partnership or investment opportunities across the drug-to-patient continuum.

  • Raidium – AI-native precision radiology platform unifying imaging workflows and generating advanced imaging biomarkers with a foundation model to accelerate clinical practice and research.

  • DeepLife – digital cell twins transforming target discovery and drug design

  • ArcaScience – AI benefit/risk intelligence to optimize and de-risk drug development

  • Surge – immune-based diagnostics enhancing surgical safety and post-operative management

🤝 The morning will conclude with structured networking and targeted introductions, designed to turn conversations into next steps—strategic collaborations, pilots, BD discussions, or investment follow-ups.

🇫🇷🇺🇸 Co-organized by Cathay innovation with the official French innovation and economic organizations in San Francisco—French Tech SF, Business France, the French American Chamber of Commerce, and the French Consulate—this breakfast pitch session showcases the very best of French innovation while providing a valuable platform for collaboration. 🚀

📍 Hosted at the San Francisco office of Cathay Innovation — a global venture capital firm investing in category-defining startups across sectors, including healthcare (Owkin, Bioptimus, Nabla, Aqemia, Inato, Tucuvi, and more). Cathay Innovation manages Europe’s largest AI-dedicated venture fund ($1B), investing globally, and is backed by strategic partners including Sanofi.

Location
Cathay Innovation
101 Mission St, San Francisco, CA 94105, USA
75 Went